CAPTRUST Financial Advisors’s 2seventy bio TSVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-116,898
Closed -$499K 2639
2023
Q4
$499K Buy
116,898
+105,607
+935% +$325K ﹤0.01% 1739
2023
Q3
$44.3K Sell
11,291
-19,211
-63% -$126K ﹤0.01% 2490
2023
Q2
$309K Sell
30,502
-7
-0% -$74 ﹤0.01% 1949
2023
Q1
$311K Buy
+30,509
New +$349K ﹤0.01% 1721
2022
Q3
Sell
-10,616
Closed -$140K 3910
2022
Q2
$140K Buy
10,616
+684
+7% +$9.32K ﹤0.01% 1956
2022
Q1
$169K Buy
9,932
+1,484
+18% +$25.2K ﹤0.01% 1844
2021
Q4
$217K Buy
+8,448
New +$263K ﹤0.01% 1587

Other funds holding TSVT

CAPTRUST Financial Advisors's TSVT Position: Q1 2024 in Review

CAPTRUST Financial Advisors sold out of 2seventy bio (TSVT) in Q1 2024, closing a stake of 116,898 shares — an estimated $499K sold.

CAPTRUST Financial Advisors first reported a position in TSVT in Q4 2021 and held it in 7 quarters. The position peaked at $499K in Q4 2023. 117 funds tracked by Wall St. Rank hold TSVT as of Q1 2024.

  • CAPTRUST Financial Advisors reported no remaining 2seventy bio position as of Q1 2024 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 116,898 2seventy bio shares in Q1 2024, an estimated $499K.
  • CAPTRUST Financial Advisors first reported a position in 2seventy bio in Q4 2021 and held it in 7 quarters.
  • CAPTRUST Financial Advisors's 2seventy bio position peaked at $499K in Q4 2023.
  • 117 funds tracked by Wall St. Rank held 2seventy bio as of Q1 2024.

Based on CAPTRUST Financial Advisors's 13F filing for Q1 2024, filed 15 May 2024.